Atea Pharmaceuticals Inc.
3.19
0.04 (1.27%)
At close: Jan 15, 2025, 12:55 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -1.87 -3.45 6.11 -317.03 -186.23 -158.3
PS Ratio n/a n/a 2.11 70.82 n/a n/a
PB Ratio 0.46 0.63 1.04 6.29 -50.57 -39.68
P/FCF Ratio -2.98 -3.26 -8.51 11.61 -195.58 -181.17
P/OCF Ratio -2.98 -3.31 -8.51 11.61 -195.61 -181.44
OCF/S Ratio n/a n/a -0.25 6.10 n/a n/a
Debt / Equity Ratio 0.00 0.00 0.00 n/a n/a n/a
Quick Ratio 18.24 35.77 13.58 2.73 9.00 19.71
Current Ratio 18.24 35.77 13.58 2.73 9.00 19.71
Asset Turnover n/a n/a 0.45 0.06 n/a n/a
Interest Coverage n/a -11.72 n/a n/a n/a n/a
Return on Equity (ROE) -0.24 -0.18 0.17 -0.02 0.27 0.25
Return on Assets (ROA) -0.23 -0.17 0.16 -0.01 -0.61 -0.26
Return on Capital (ROIC) -0.29 -0.2 0.19 -0.02 -0.74 -0.29
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a 99.99% 99.96% n/a n/a
Net Profit Margin n/a n/a 34.49% -22.34% n/a n/a
Pretax Profit Margin n/a n/a 39.44% -22.51% n/a n/a
Operating Profit Margin n/a n/a 39.38% -22.68% n/a n/a
FCF Margin n/a n/a -24.76% 610.10% n/a n/a
EBITDA Margin n/a n/a 39.39% -22.64% n/a n/a